The Antimicrobial Resistance Surveillance Market was valued at USD 5.90 billion in 2023 and is projected to reach USD 9.50 billion by 2032, expanding at a CAGR of 5.47% during the forecast period 2024–2032, according to the latest industry analysis by SNS Insider. This growth trajectory is being driven by increased investments in public health infrastructure, growing incidences of antimicrobial-resistant infections, and rapid advancements in surveillance technologies.
Antimicrobial Resistance Surveillance Market Size
Governments across the globe are making antimicrobial resistance (AMR) a top priority, with programs focused on better detection, prevention, and research initiatives. Additionally, global health organizations such as the World Health Organization (WHO) and the Centers for Disease Control and Prevention (CDC) are actively supporting the development of robust surveillance systems to monitor antimicrobial resistance trends across various regions.
The market’s momentum is also supported by innovations in laboratory information systems, big data analytics, and artificial intelligence integration, which make data collection, analysis, and response mechanisms more efficient and timely. Furthermore, the increasing partnerships between public health institutions and private technology companies have significantly contributed to rapid market expansion.
Market Drivers and Trends
One of the key driving forces behind the market's growth is the rise in hospital-acquired infections and the global threat posed by drug-resistant pathogens. These challenges demand swift identification of resistance patterns, real-time monitoring, and streamlined reporting – all of which are enabled by cutting-edge AMR surveillance solutions.
Key market participants are also investing in user-friendly surveillance platforms that combine cloud-based infrastructure and machine learning algorithms, allowing stakeholders to predict resistance trends and take proactive measures. Moreover, the market is seeing greater adoption in low- and middle-income countries, where international funding programs are aiding the setup of AMR tracking systems.
Regional Insights
North America currently dominates the Antimicrobial Resistance Surveillance Market, followed by Europe and Asia-Pacific. This is due to well-established healthcare frameworks, strong research and development capabilities, and a high level of awareness regarding AMR. Meanwhile, Asia-Pacific is anticipated to witness the fastest growth rate due to a surge in infectious disease cases, growing healthcare expenditure, and government policies targeted at improving AMR surveillance.
Key Players in the Market
Some of the major companies operating in this sector include bioMérieux, Thermo Fisher Scientific, BD (Becton, Dickinson and Company), Abbott Laboratories, and Roche Diagnostics. These companies are focusing on strategic acquisitions, partnerships, and product innovations to strengthen their market positions and improve global AMR surveillance capabilities.
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Jagney Dave - Vice President of Client Engagement
Phone: +1-315 636 4242 (US) | +44- 20 3290 5010 (UK)
Email: info@snsinsider.com